Literature DB >> 18790609

Combined efficacy of clarithromycin plus cefazolin or vancomycin against Staphylococcus aureus biofilms formed on titanium medical devices.

Shigeru Fujimura1, Tetsuro Sato, Takeshi Mikami, Toshiaki Kikuchi, Kazunori Gomi, Akira Watanabe.   

Abstract

In this study, we investigated the in vitro efficacy of clarithromycin (CLA) combined with cefazolin (CFZ) or vancomycin (VCM) against Staphylococcus aureus biofilms formed on titanium devices in order to confirm the efficacy of eradication therapies against device-related infection. The distribution of CLA in muscle tissue surrounding bone was also investigated by liquid chromatography/tandem mass spectrometry in 10 orthopaedic patients. Biofilm formation and eradication of S. aureus were monitored by scanning electron microscopy and using double-staining dyes, respectively. Although S. aureus biofilms were not eradicated by CLA, CFZ or VCM alone, CLA combined with CFZ or VCM destroyed biofilms, and S. aureus eradication was clearly observed 72 h later. This in vitro study showed that treatment with CLA plus CFZ or VCM destroyed staphylococcal biofilms formed on medical devices and eradicated S. aureus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18790609     DOI: 10.1016/j.ijantimicag.2008.06.030

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  17 in total

1.  The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?

Authors:  Cristina El Haj; Oscar Murillo; Alba Ribera; Dolors Garcia-Somoza; Fe Tubau; Carmen Cabellos; Javier Cabo; Javier Ariza
Journal:  Med Microbiol Immunol       Date:  2016-09-17       Impact factor: 3.402

2.  Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.

Authors:  Jorge Parra-Ruiz; Celine Vidaillac; Warren E Rose; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

3.  Estimation of Minimum Biofilm Eradication Concentration (MBEC) on In Vivo Biofilm on Orthopedic Implants in a Rodent Femoral Infection Model.

Authors:  Yu Okae; Kohei Nishitani; Akio Sakamoto; Toshiyuki Kawai; Takuya Tomizawa; Motoo Saito; Yutaka Kuroda; Shuichi Matsuda
Journal:  Front Cell Infect Microbiol       Date:  2022-07-01       Impact factor: 6.073

4.  Antibiotic activity against naive and induced Streptococcus pneumoniae biofilms in an in vitro pharmacodynamic model.

Authors:  Nathalie M Vandevelde; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

5.  Antibiotic Combinations with Daptomycin for Treatment of Staphylococcus aureus Infections.

Authors:  Kristina Nadrah; Franc Strle
Journal:  Chemother Res Pract       Date:  2011-04-18

6.  Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial Biofilm.

Authors:  Ashley D Hall Snyder; Celine Vidaillac; Warren Rose; John P McRoberts; Michael J Rybak
Journal:  Infect Dis Ther       Date:  2014-12-18

7.  Efficacy of clarithromycin on biofilm formation of methicillin-resistant Staphylococcus pseudintermedius.

Authors:  Matthew Dicicco; Suresh Neethirajan; Ameet Singh; J Scott Weese
Journal:  BMC Vet Res       Date:  2012-11-21       Impact factor: 2.741

8.  Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm.

Authors:  Larissa Lutz; Dariane Castro Pereira; Rodrigo Minuto Paiva; Alexandre Prehn Zavascki; Afonso Luis Barth
Journal:  BMC Microbiol       Date:  2012-09-08       Impact factor: 3.605

9.  Suitability of Biomorphic Silicon Carbide Ceramics as Drug Delivery Systems against Bacterial Biofilms.

Authors:  P Díaz-Rodríguez; A Pérez-Estévez; R Seoane; P González; J Serra; M Landin
Journal:  ISRN Pharm       Date:  2013-07-07

10.  In vitro synergism of fosfomycin and clarithromycin antimicrobials against methicillin-resistant Staphylococcus pseudintermedius.

Authors:  Matthew DiCicco; Suresh Neethirajan; J Scott Weese; Ameet Singh
Journal:  BMC Microbiol       Date:  2014-05-19       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.